Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia × Voriconazole × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 1 Leukemia 1 Invasive Fungal Infections 1 Hematologic Neoplasms 1

Interventions

nilotinib 4 Cytarabine 3 Filgrastim 2 Cyclophosphamide 2 Aprepitant 2 Antilymphocyte Serum 2 rasburicase 1 fludarabine phosphate 1 fludarabine 1 bosutinib 1 blinatumomab 1 aldesleukin 1 Water 1 Voriconazole 1 Urate Oxidase 1 Tobacco Use Cessation Devices 1 Thiotepa 1 Rituximab 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Prilocaine 1 Polymerase Chain Reaction 1 Pharmacogenomic Testing 1 Pentostatin 1 Palonosetron 1 Oxygen 1 Interleukin-2 1 Inotuzumab Ozogamicin 1 Histamine 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00143312 2009-10-06

VOSIFI

Pfizer

Phase 4 Completed

45 enrolled 15 charts

Other hematologic neoplasm

Invasive Fungal Infections, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡